🧫
experiment
Fluid biomarker pT217Tau demonstrates that soluble tau pathology begins early in disease progression.
🧫 Experiment Protocol
Clinical
proposed
SUMMARY
Fluid biomarker pT217Tau demonstrates that soluble tau pathology begins early in disease progression.
METHODOLOGY NOTES
Fluid biomarker detection of phosphorylated tau (pT217Tau)
species: homo_sapiens
View on SciDEX ↗